GlassScriptPhysician profile
Jillian H Van Essendelft
NPI 1083209217
$769.17
in general payments reported to CMS, 2019-2025
18 companies · $439 in 2025
The $439 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $94.24 · 2024: $236 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $769.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $769.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $200.94 | 2024-2025 | Wegovy |
| Sumitomo Pharma America, INC. | $97.91 | 2025 | Myfembree, Gemtesa |
| Convatec INC. | $90.49 | 2023-2024 | |
| Organon LLC | $42.81 | 2025 | Nexplanon |
| Smith+Nephew, INC. | $41.16 | 2023 | Oasis, Grafix Pl, Regranex |
| Grifols USA, LLC | $38.33 | 2025 | Prolastin-C Liquid |
| Mayne Pharma Commercial LLC | $32.96 | 2025 | |
| Astellas Pharma US INC | $24.74 | 2025 | Veozah |
| Coopersurgical, INC. | $23.82 | 2025 | Paragard T 380a |
| Abbvie INC. | $23.29 | 2025 | |
| Lsi Solutions INC | $23.07 | 2025 | Fornisee |
| Evofem Biosciences, INC. | $22.16 | 2025 | Phexxi, Solosec, Phexx |
| Molnlycke Health Care US, LLC | $21.15 | 2025 | Exufiber, Mextra Superabsorbant, Mepilex Border Flex |
| Paratek Pharmaceuticals, INC. | $19.08 | 2023 | Nuzyra |
| Bayer Healthcare Pharmaceuticals INC. | $18.46 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $17.83 | 2025 | Gattex |
| Next Science LLC | $17.49 | 2023 | Blastx, Surgx, Xperience |
| Exeltis, USA INC. | $13.48 | 2025 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Van Essendelft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.